Back
Matinas BioPharma Holdings Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25
MTNB
Matinas BioPharma Holdings
Last Price:
$0.99
Seasonality Move:
12.45%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MTNB is experiencing slight buying pressure.
Matinas BioPharma Holdings Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.97 | Buy |
20-day SMA: | 0.93 | Buy |
50-day SMA: | 0.84 | Buy |
200-day SMA: | 1.02 | Sell |
8-day EMA: | 0.72 | Buy |
20-day EMA: | 0.39 | Buy |
50-day EMA: | 0.18 | Buy |
200-day EMA: | 0.05 | Buy |
Matinas BioPharma Holdings Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.25 | Buy |
Relative Strength Index (14 RSI): | 59.85 | Buy |
Chaikin Money Flow: | 6612 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.88 - 0.98) | Buy |
Bollinger Bands (100): | (0.54 - 0.86) | Buy |
Matinas BioPharma Holdings Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Matinas BioPharma Holdings Stock
Is Matinas BioPharma Holdings Stock a Buy?
-
Matinas BioPharma Holdings share price is 1.00 while MTNB 8-day simple moving average is 0.97, which is a Buy signal.
-
The stock price of MTNB is 1.00 while Matinas BioPharma Holdings 20-day SMA is 0.93, which makes it a Buy.
-
Matinas BioPharma Holdings 50-day simple moving average is 0.84 while MTNB share price is 1.00, making it a Buy technically.
-
MTNB stock price is 1.00 and Matinas BioPharma Holdings 200-day simple moving average is 1.02, creating a Sell signal.
MTNB Technical Analysis vs Fundamental Analysis
Sell
25
Matinas BioPharma Holdings (MTNB)
is a Sell
Is Matinas BioPharma Holdings a Buy or a Sell?
-
Matinas BioPharma Holdings stock is rated a SellThe current Matinas BioPharma Holdings [MTNB] share price is $1.00. The Score for MTNB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Matinas BioPharma Holdings Stock Info
Market Cap:
5.1M
Price in USD:
1.00
Share Volume:
42.1K
Matinas BioPharma Holdings 52-Week Range
52-Week High:
9.60
52-Week Low:
0.47
Sell
25
Matinas BioPharma Holdings (MTNB)
is a Sell
Matinas BioPharma Holdings Share Price Forecast
-
What is the Matinas BioPharma Holdings stock price today?The Matinas BioPharma Holdings stock price is 1.00 USD today.
-
Will MTNB stock go up or go down?Matinas BioPharma Holdings> share price is forecast to RISE/FALL based on technical indicators
-
Is Matinas BioPharma Holdings overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Matinas BioPharma Holdings is overvalued.
Is Matinas BioPharma Holdings Stock a Buy?
-
Matinas BioPharma Holdings share price is 1.00 while MTNB 8-day exponential moving average is 0.72, which is a Buy signal.
-
The stock price of MTNB is 1.00 while Matinas BioPharma Holdings 20-day EMA is 0.39, which makes it a Buy.
-
Matinas BioPharma Holdings 50-day exponential moving average is 0.18 while MTNB share price is 1.00, making it a Buy technically.
-
MTNB stock price is 1.00 and Matinas BioPharma Holdings 200-day simple moving average is 0.05, creating a Buy signal.
Fundamental Analysis of Matinas BioPharma Holdings
Is Matinas BioPharma Holdings a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.56 per share, and a decrease next year of $2.50 per share.
Technical Analysis of Matinas BioPharma Holdings
Should I short Matinas BioPharma Holdings stock?
-
MTNB Moving Average Covergence Divergence (MACD) indicator is 0.25, suggesting Matinas BioPharma Holdings is a Buy
-
Matinas BioPharma Holdings Relative Strength Index (RSI) is 59.85, which suggest Matinas BioPharma Holdings is overbought
-
The Bollinger Bands (25) for Matinas BioPharma Holdings is (0.88 - 0.98), which suggest Matinas BioPharma Holdings is a Buy
-
The Bollinger Bands (100) for Matinas BioPharma Holdings is (0.54 - 0.86), which suggest Matinas BioPharma Holdings is a Buy
* Matinas BioPharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.